dummies
 
 

Suchen und Finden

Titel

Autor/Verlag

Inhaltsverzeichnis

Nur ebooks mit Firmenlizenz anzeigen:

 

Cardiovascular Disease in the Elderly

Cardiovascular Disease in the Elderly

von: Gary Gerstenblith

Humana Press, 2007

ISBN: 9781592599417 , 418 Seiten

Format: PDF

Kopierschutz: Wasserzeichen

Windows PC,Mac OSX Apple iPad, Android Tablet PC's

Preis: 160,49 EUR

Exemplaranzahl:


  • Seniorenspielbuch - Reaktivierung Dementer in Pflege und Betreuung
    Role of Physical Exercise in Preventing Disease and Improving the Quality of Life
    Betriebliche Gesundheitsförderung erfolgreich umsetzen - Praxishandbuch für Pflege- und Sozialdienste
    Color Atlas of Infective Endocarditis
    Stroke Prevention in Clinical Practice
    Small-Bowel Obstruction - CT Features with Plain Film and US correlations
    Dynamic Regression Models for Survival Data
    Brücken zwischen dir und mir - Betreuung zu Hause erleben
  • Surgical Neuroangiography - Vol. 3: Clinical and Interventional Aspects in Children
    Kinderorthopädie in der Praxis
    Pediatric Inflammatory Bowel Disease
    Klinische Kinderkardiologie - Diagnostik und Therapie der angeborenen Herzfehler
    Pädiatrische Rheumatologie
    Management of Prader-Willi Syndrome
    Clinical Forensic Medicine - A Physician's Guide
    Color Atlas of Strabismus Surgery - Strategies and Techniques
 

Mehr zum Inhalt

Cardiovascular Disease in the Elderly


 

A panel of clinicians, researchers, and leaders in the field review and discuss the latest findings on the pathophysiology, diagnosis, and management of cardiovascular disease in the older patient. The authors explain the physiological changes associated with the normal aging process that may lead to the development of disease, to adverse consequences once disease develops, and which alter the risk-benefit equation for medical and other interventions designed to diagnose, assess, and treat cardiovascular disease. The focus is on particularly common syndromes in the elderly, including cardiac failure with normal ejection fraction, isolated systolic hypertension, and atrial fibrillation. Wherever possible, the authors take an evidence-based approach to recommendations and rely heavily on prospective clinical trials.